Following the controversial births of the first gene-edited babies, a major focus of the Third International Summit on Human Genome Editing was responsible use of CRISPR.
Rigor académico, oficio periodístico
Artículos sobre Germline editing
Mostrando todos artículos
We propose five principles that could guide a proper ethical and legal framework for germline editing and similar technologies.
We could start making our genomes equipped to deal with more frequent pandemics. But it may come at a cost.
CRISPR technology could have momentous effects if it’s used to edit genes that will be inherited by future generations. Researchers and ethicists continue to weigh appropriate guidelines.
A Russian scientist is preparing to do germline gene editing. Here’s why that’s a problem.
Scientists and ethicists have called for a five-year moratorium on editing human genes that will pass on to future generations. Yes, society needs to figure out how to proceed – but is this the best way?
CRISPR gene editing should learn from the Slow Food movement. Scientists must allow time for critical conversations and perfecting of techniques before rewriting the source code of humanity.
Scientists worldwide are calling for a moratorium on gene editing in germline cells. But what is a germline cell? How does it differ from other cells in our body? Why does it matter if we edit them?
A team in the U.S. is said to have safely and effectively altered human embryos. The news is a reminder that citizens must be consulted on developments potentially affecting the future of the species.
The news may have come as a surprise, but it probably shouldn’t have. A bioethics expert walks through how big a deal this announcement is – and what we should be considering now.
Controversy over a Chinese study that used CRISPR-Cas9 gene-editing technology shows how the West still looks at the East through the lens of Orientalism.
We’re not quite there yet but there is already a potential blueprint for editing the human germline.
The International Summit on Human Gene Editing drew a distinction between editing an individual’s body cells and editing germline cells that would pass changes to future generations. Does that make sense?
Should the gathering of experts from around the world that’s considering the scientific, ethical, and governance issues linked to research into gene editing ring alarm bells?
While gene editing offers the exciting potential for disease therapies, using it on human embryos opens up a can of worms.
Since science made it possible to research manipulating the cells that are linked to reproduction, the naysayers have carried the day. But how solid are their objections really?
Principales colaboradores
-
Assistant Professor in Biomedical Ethics, National University of Singapore
-
Professor Emeritus of Applied Philosophy, Glasgow Caledonian University
-
Post Doctoral Fellow, University of KwaZulu-Natal
-
Research Group Head, Germ Cell Development and Epigenetics, Hudson Institute
-
Director of Germline and Epigenomics Research at the Gurdon Institute, University of Cambridge
-
Assistant Professor of Bioethics, National University of Singapore
-
Distinguished Research Professor, Emerita, Dalhousie University
-
Law Dean; Professor of Law; and Professor of Bioethics & Public Health, Case Western Reserve University
-
Director of Research and Professor of Pathology, Dalhousie University
-
Vanier Scholar and Ph.D. Candidate in Microbiology and Immunology, Dalhousie University
-
Professor, Departments of Human Genetics and Biostatistics, University of Pittsburgh
-
Dean of the College of Science, Professor of Biochemistry, Rochester Institute of Technology
-
Clinician Scientist and Consultant Haematologist, University of Oxford
-
Postdoctoral Scholar, University of California, San Diego
-
PhD Candidate at Science, Technology, Engineering and Public Policy, UCL
